Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Jahrestagung der Österreichischen Gesellschaft für Rheumatologie & Rehabilitation
26.–28. November 2015
Abstracts der Posterpräsentationen

Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen 2015; 22 (4): 105-131

Volltext (PDF)    Übersicht   

Aktuelles Bild - Abb. 1: Intracellular Calcium Abb. 2: Diagnostic Groups Abb. 3: ADA-positive Biologikapatienten Abb. 4: Diagnoseverzögerung Abb. 5A-B: Therapieansprechen
Abbildung 1: Intracellular Calcium
Steinecker-Frohnwieser B, et al. Agonist-induced changes in intracellular calcium [Ca2+]i . MUG-Chor1 cells were loaded with Fura-2 and fluorescence was measured when cells were perfused with different agonists. A representative time course showing agonistinduced changes of the ratio 340/380 is given (A). Summary of the peak calcium levels reached by application of different agonists is shown in (B).
 
Intracellular Calcium
Vorheriges BildNächstes Bild   


Abbildung 1: Intracellular Calcium
Steinecker-Frohnwieser B, et al. Agonist-induced changes in intracellular calcium [Ca2+]i . MUG-Chor1 cells were loaded with Fura-2 and fluorescence was measured when cells were perfused with different agonists. A representative time course showing agonistinduced changes of the ratio 340/380 is given (A). Summary of the peak calcium levels reached by application of different agonists is shown in (B).
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung